Injection of dendritic cells, pulsated by tumor lysate or mucin, containing CA 125 antigen, led to a more than 50% inhibition of tumor growth in female CBA mice with transplanted mouse pseudomucinous CaO-1 ovarian carcinoma in comparison with the control. Tumor-associated CA 125 antigen can be used for obtaining dendritic cell vaccines against ovarian malignant tumors. This trend will extend the potentialities of application of antitumor vaccines based on dendritic cells, as clinical use of this technology is limited by the need in patient’s tumor material. Mucin, containing Ca 125 antigen, can be isolated from patient’s serum or obtained by gene engineering technologies as a recombinant peptide.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
B. S. Amandzholov, S. M. Sitdikova, Yu. S. Lebedin, et al., Byull. Eksp. Biol. Med., 128, No. 4, 456-458 (2000).
S. M. Sitdikova, B. S. Amandzholov, V. Yu. Sel’chuk, et al., Ibid., 462-464.
F. Benencia, M. C. Courreges, and G. Coucos, J. Transpl. Med., 6, 21 (2008).
J. J. Hernando, T. W. Park, and W. C. Kuhn, Anticancer Res., 23, No. 5b, 4293-4303 (2003).
A. N. Gordon, B. C. Schultes, H. Gallion, et al., Gynecol. Oncol., 94, No. 2, 340-351 (2004).
U. Wagner, H. Schlebusch, S. Kohler, et al., Hybridoma, 16, No. 1, 33-40 (1997).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 147, No. 2, pp. 187-189, February, 2009
Rights and permissions
About this article
Cite this article
Sitdikova, S.M., Kiselevskii, M.V., Sel’chuk, V.Y. et al. Evaluation of Immunotherapy Efficiency in Mouse CaO-1 Ovarian Carcinoma Treated by Vaccines Based on Dendritic Cells. Bull Exp Biol Med 147, 226–228 (2009). https://doi.org/10.1007/s10517-009-0480-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-009-0480-8